| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.009 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |